Caxton Associates (New York)’s Procter & Gamble PG Stock Holding History

Caxton Associates (New York)’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-100,000	Closed	-$7.81M	–	512
2018 Q2	$7.81M	Buy	+100,000	New	+$7.53M	0.39%	46
2015 Q2	–	Sell	-50,000	Closed	-$4.1M	–	188
2015 Q1	$4.1M	Buy	+50,000	New	+$4.3M	0.17%	97

Other funds holding PG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Caxton Associates (New York)'s PG Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Procter & Gamble (PG) in Q1 2024, closing a stake of 5,290 shares — an estimated $775K sold.

Caxton Associates (New York) first reported a position in PG in Q3 2016 and held it in 14 quarters. The position peaked at $8.81M in Q1 2019. 3,649 funds tracked by Wall St. Rank hold PG as of Q1 2024.

Caxton Associates (New York) reported no remaining Procter & Gamble position as of Q1 2024 after selling out during the quarter.
Caxton Associates (New York) sold 5,290 Procter & Gamble shares in Q1 2024, an estimated $775K.
Caxton Associates (New York) first reported a position in Procter & Gamble in Q3 2016 and held it in 14 quarters.
Caxton Associates (New York)'s Procter & Gamble position peaked at $8.81M in Q1 2019.
3,649 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.